Abstract
In an era of guideline propagation, this case helps raise the question, Does quality cancer care now require that we always follow guidelines exactly, or do some circumstances still require a more individualized approach?
MeSH terms
-
Breast Neoplasms / drug therapy*
-
Chemotherapy, Adjuvant / standards
-
Diphosphonates / therapeutic use
-
Ethics, Medical
-
Evidence-Based Medicine / ethics
-
Female
-
Guideline Adherence / ethics
-
Humans
-
Imidazoles / therapeutic use
-
Middle Aged
-
North Carolina
-
Patient Preference
-
Practice Guidelines as Topic*
-
Quality of Health Care*
-
Secondary Prevention
-
Zoledronic Acid
Substances
-
Diphosphonates
-
Imidazoles
-
Zoledronic Acid